ID   PA21B_HUMAN             Reviewed;         148 AA.
AC   P04054; B2R4H5; Q3KPI1;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 3.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Phospholipase A2;
DE            EC=3.1.1.4;
DE   AltName: Full=Group IB phospholipase A2;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 1B;
DE   Flags: Precursor;
GN   Name=PLA2G1B; Synonyms=PLA2, PLA2A, PPLA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Lung;
RX   PubMed=3028739; DOI=10.1089/dna.1.1986.5.519;
RA   Seilhamer J.J., Randall T.L., Yamanaka M., Johnson L.K.;
RT   "Pancreatic phospholipase A2: isolation of the human gene and cDNAs
RT   from porcine pancreas and human lung.";
RL   DNA 5:519-527(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 16-22.
RC   TISSUE=Pancreas;
RX   PubMed=7060561; DOI=10.1111/j.1432-1033.1982.tb05855.x;
RA   Grataroli R., Dijkman R., Dutilh C.E., van der Ouderaa F.,
RA   de Haas G.H., Figarella C.;
RT   "Studies on prophospholipase A2 and its enzyme from human pancreatic
RT   juice. Catalytic properties and sequence of the N-terminal region.";
RL   Eur. J. Biochem. 122:111-117(1982).
RN   [8]
RP   PROTEIN SEQUENCE OF 23-148.
RC   TISSUE=Pancreas;
RX   PubMed=6349696; DOI=10.1016/0167-4838(83)90126-7;
RA   Verheij H.M., Westerman J., Sternby B., de Haas G.H.;
RT   "The complete primary structure of phospholipase A2 from human
RT   pancreas.";
RL   Biochim. Biophys. Acta 747:93-99(1983).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 16-148, DISULFIDE BONDS,
RP   SUBUNIT, AUTOPROTEOLYTIC CLEAVAGE, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=19297324; DOI=10.1074/jbc.M808029200;
RA   Xu W., Yi L., Feng Y., Chen L., Liu J.;
RT   "Structural insight into the activation mechanism of human pancreatic
RT   prophospholipase A2.";
RL   J. Biol. Chem. 284:16659-16666(2009).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides, this releases
CC       glycerophospholipids and arachidonic acid that serve as the
CC       precursors of signal molecules. {ECO:0000269|PubMed:19297324}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035, ECO:0000255|PROSITE-ProRule:PRU10036}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer or homodimer (By similarity). The inactive pro-
CC       form is a homotrimer. {ECO:0000250, ECO:0000269|PubMed:19297324}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19297324}.
CC       Note=secreted from pancreatic acinar cells in its inactive form.
CC   -!- PTM: Activated by trypsin cleavage in the duodenum. Can also be
CC       activated by thrombin or autocatalytically.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS SNPs;
CC       URL="http://egp.gs.washington.edu/data/pla2g1b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M21056; AAA60107.1; -; Genomic_DNA.
DR   EMBL; M22970; AAA60107.1; JOINED; Genomic_DNA.
DR   EMBL; M21054; AAA36450.1; -; mRNA.
DR   EMBL; AK311830; BAG34772.1; -; mRNA.
DR   EMBL; AY438977; AAR05441.1; -; Genomic_DNA.
DR   EMBL; AC003982; AAB95635.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW98184.1; -; Genomic_DNA.
DR   EMBL; BC106725; AAI06726.1; -; mRNA.
DR   EMBL; BC106726; AAI06727.1; -; mRNA.
DR   CCDS; CCDS9195.1; -.
DR   PIR; C25793; PSHU.
DR   RefSeq; NP_000919.1; NM_000928.2.
DR   UniGene; Hs.992; -.
DR   PDB; 1YSK; Model; -; A=23-146.
DR   PDB; 3ELO; X-ray; 1.55 A; A=16-148.
DR   PDBsum; 1YSK; -.
DR   PDBsum; 3ELO; -.
DR   ProteinModelPortal; P04054; -.
DR   SMR; P04054; -.
DR   BioGrid; 111336; 2.
DR   IntAct; P04054; 1.
DR   STRING; 9606.ENSP00000312286; -.
DR   BindingDB; P04054; -.
DR   ChEMBL; CHEMBL4426; -.
DR   DrugBank; DB07836; 1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL.
DR   DrugBank; DB03565; 1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB02938; Heptanoic Acid.
DR   DrugBank; DB03633; Lpc-Ether.
DR   DrugBank; DB02448; N-Tridecanoic Acid.
DR   DrugBank; DB04552; Niflumic Acid.
DR   DrugBank; DB02795; P-Anisic Acid.
DR   DrugBank; DB07657; PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER.
DR   DrugBank; DB03587; Pyruvoyl Group.
DR   DrugBank; DB00795; Sulfasalazine.
DR   GuidetoPHARMACOLOGY; 1416; -.
DR   SwissLipids; SLP:000001083; -.
DR   iPTMnet; P04054; -.
DR   BioMuta; PLA2G1B; -.
DR   DMDM; 129404; -.
DR   PaxDb; P04054; -.
DR   PeptideAtlas; P04054; -.
DR   PRIDE; P04054; -.
DR   DNASU; 5319; -.
DR   Ensembl; ENST00000308366; ENSP00000312286; ENSG00000170890.
DR   GeneID; 5319; -.
DR   KEGG; hsa:5319; -.
DR   UCSC; uc001tyd.3; human.
DR   CTD; 5319; -.
DR   DisGeNET; 5319; -.
DR   GeneCards; PLA2G1B; -.
DR   HGNC; HGNC:9030; PLA2G1B.
DR   HPA; CAB022329; -.
DR   HPA; HPA047822; -.
DR   HPA; HPA060803; -.
DR   MIM; 172410; gene.
DR   neXtProt; NX_P04054; -.
DR   OpenTargets; ENSG00000170890; -.
DR   PharmGKB; PA33361; -.
DR   eggNOG; KOG4087; Eukaryota.
DR   eggNOG; ENOG411283D; LUCA.
DR   GeneTree; ENSGT00760000119160; -.
DR   HOGENOM; HOG000231749; -.
DR   HOVERGEN; HBG008137; -.
DR   InParanoid; P04054; -.
DR   KO; K01047; -.
DR   OMA; WQFRKMI; -.
DR   OrthoDB; EOG091G0UZ3; -.
DR   PhylomeDB; P04054; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   SIGNOR; P04054; -.
DR   ChiTaRS; PLA2G1B; human.
DR   EvolutionaryTrace; P04054; -.
DR   GeneWiki; PLA2G1B; -.
DR   GenomeRNAi; 5319; -.
DR   PRO; PR:P04054; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000170890; -.
DR   CleanEx; HS_PLA2G1B; -.
DR   ExpressionAtlas; P04054; baseline and differential.
DR   Genevisible; P04054; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0030141; C:secretory granule; IEA:Ensembl.
DR   GO; GO:0032052; F:bile acid binding; ISS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:BHF-UCL.
DR   GO; GO:0004623; F:phospholipase A2 activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IDA:BHF-UCL.
DR   GO; GO:0007015; P:actin filament organization; TAS:ProtInc.
DR   GO; GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL.
DR   GO; GO:0032431; P:activation of phospholipase A2 activity; TAS:BHF-UCL.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0050482; P:arachidonic acid secretion; TAS:BHF-UCL.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015758; P:glucose transport; ISS:BHF-UCL.
DR   GO; GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB.
DR   GO; GO:0032637; P:interleukin-8 production; ISS:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0044240; P:multicellular organismal lipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISS:BHF-UCL.
DR   GO; GO:0002446; P:neutrophil mediated immunity; ISS:BHF-UCL.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; IDA:BHF-UCL.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISS:BHF-UCL.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IC:BHF-UCL.
DR   GO; GO:0050778; P:positive regulation of immune response; ISS:BHF-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0050714; P:positive regulation of protein secretion; TAS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Calcium; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Polymorphism;
KW   Reference proteome; Secreted; Signal; Zymogen.
FT   SIGNAL        1     15       {ECO:0000269|PubMed:7060561}.
FT   PROPEP       16     22       Activation peptide.
FT                                {ECO:0000269|PubMed:6349696}.
FT                                /FTId=PRO_0000022739.
FT   CHAIN        23    148       Phospholipase A2.
FT                                {ECO:0000269|PubMed:3028739}.
FT                                /FTId=PRO_0000022740.
FT   ACT_SITE     70     70       {ECO:0000250}.
FT   ACT_SITE    121    121       {ECO:0000250}.
FT   METAL        50     50       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        52     52       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        54     54       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        71     71       Calcium. {ECO:0000250}.
FT   DISULFID     33     99       {ECO:0000269|PubMed:19297324}.
FT   DISULFID     49    146       {ECO:0000269|PubMed:19297324}.
FT   DISULFID     51     67       {ECO:0000269|PubMed:19297324}.
FT   DISULFID     66    127       {ECO:0000269|PubMed:19297324}.
FT   DISULFID     73    120       {ECO:0000269|PubMed:19297324}.
FT   DISULFID     83    113       {ECO:0000269|PubMed:19297324}.
FT   DISULFID    106    118       {ECO:0000269|PubMed:19297324}.
FT   VARIANT      16     16       D -> A (in dbSNP:rs5632).
FT                                /FTId=VAR_011911.
FT   VARIANT      89     89       N -> K (in dbSNP:rs5636).
FT                                /FTId=VAR_011913.
FT   VARIANT      89     89       N -> T (in dbSNP:rs5635).
FT                                /FTId=VAR_011912.
FT   CONFLICT    144    144       Missing (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        21     23       {ECO:0000244|PDB:3ELO}.
FT   HELIX        25     30       {ECO:0000244|PDB:3ELO}.
FT   HELIX        31     33       {ECO:0000244|PDB:3ELO}.
FT   HELIX        40     44       {ECO:0000244|PDB:3ELO}.
FT   STRAND       45     47       {ECO:0000244|PDB:3ELO}.
FT   TURN         48     50       {ECO:0000244|PDB:3ELO}.
FT   STRAND       51     54       {ECO:0000244|PDB:3ELO}.
FT   HELIX        62     77       {ECO:0000244|PDB:3ELO}.
FT   HELIX        81     83       {ECO:0000244|PDB:3ELO}.
FT   TURN         84     87       {ECO:0000244|PDB:3ELO}.
FT   STRAND       97    100       {ECO:0000244|PDB:3ELO}.
FT   STRAND      103    106       {ECO:0000244|PDB:3ELO}.
FT   HELIX       112    130       {ECO:0000244|PDB:3ELO}.
FT   HELIX       135    137       {ECO:0000244|PDB:3ELO}.
FT   HELIX       142    145       {ECO:0000244|PDB:3ELO}.
SQ   SEQUENCE   148 AA;  16360 MW;  C8E38B2B64AEE8CB CRC64;
     MKLLVLAVLL TVAAADSGIS PRAVWQFRKM IKCVIPGSDP FLEYNNYGCY CGLGGSGTPV
     DELDKCCQTH DNCYDQAKKL DSCKFLLDNP YTHTYSYSCS GSAITCSSKN KECEAFICNC
     DRNAAICFSK APYNKAHKNL DTKKYCQS
//
